NCT00278174View on ClinicalTrials.gov

Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Kidney Cancer
Interventions
BIOLOGICAL

recombinant interferon alpha-1b

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00278174 - Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter